Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...

Troubling links tie tech money to both Greenland and Trump. The tech industry desperately needs the rare earth minerals on ...

Eric Johnston, Cantor Fitzgerald chief equity & macro strategist, joins 'Closing Bell Overtime' to talk economic and market impact of tariffs.

Cantor Fitzgerald lowered the firm’s price target on Meta Platforms (META) to $624 from $790 and keeps an Overweight rating on the shares. The ...

C.J. Muse, Cantor Fitzgerald analyst, joins CNBC's 'Squawk on the Street' to discuss how chip stocks are being impacted by new export controls.

Cantor Fitzgerald analyst C J Muse reiterated a Buy rating on Nvidia (NVDA – Research Report) yesterday and set a price target of $200.00.Stay ...

He was proven very wrong on Monday as the stock dropped to $217.41 within 45 minutes of the market opening, according to ...

Anchorage has long drawn regulatory attention. In 2022, the Office of the Comptroller of the Currency (OCC) issued ...

Bill Ackman criticized US Commerce Secretary Howard Lutnick, accusing him of having a conflict of interest due to his former ...